Tripterygium wilfordii Hook F extract - Phytomedics

Drug Profile

Tripterygium wilfordii Hook F extract - Phytomedics

Alternative Names: PMI-001; TwHF extract

Latest Information Update: 17 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phytomedics
  • Class Anti-inflammatories; Antirheumatics; Herbal medicines; Traditional-Chinese-medicine
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors; Interleukin 2 inhibitors; Nitric oxide synthase type II inhibitors; Tumour necrosis factor alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 11 Nov 2010 Phytomedics receives grant under the Qualifying Therapeutic Discovery Project Program for development of PMI 001 in Rheumatoid arthritis
  • 21 Aug 2009 Clinical development is ongoing in USA
  • 19 Aug 2009 Final efficacy and adverse events data from a phase II trial in Rheumatoid arthritis released by Phytomedics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top